Bayer Aktiengesellschaft (FRA: BAYN)
Germany
· Delayed Price · Currency is EUR
19.01
+0.16 (0.83%)
At close: Dec 20, 2024
Bayer Aktiengesellschaft Revenue
Bayer Aktiengesellschaft had revenue of 9.97B EUR in the quarter ending September 30, 2024, a decrease of -3.62%. This brings the company's revenue in the last twelve months to 46.74B, down -2.17% year-over-year. In the year 2023, Bayer Aktiengesellschaft had annual revenue of 47.64B, down -6.11%.
Revenue (ttm)
46.74B
Revenue Growth
-2.17%
P/S Ratio
n/a
Revenue / Employee
495.93K
Employees
96,931
Market Cap
18.60B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
Dec 31, 2019 | 43.55B | 6.80B | 18.52% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBayer Aktiengesellschaft News
- 4 days ago - Bayer Eye Drug Shows Positive Results in Late-Stage Trial - The Wall Street Journal
- 4 days ago - Bayer Eye Drug Shows Positive Results in Late-Stage Trial - WSJ
- 4 days ago - Bayer Partners with America's Grow-A-Row to Aid in the Fight Against Hunger in New Jersey - Business Wire
- 8 days ago - Bayer Gets EU Backing for Heart Drug, Easing Patent Concerns - BNN Bloomberg
- 11 days ago - Class action members left shocked by decision that ruled in favour of pharmaceutical giant Bayer - Australian Broadcasting Corporation
- 11 days ago - Australian women lose class action against Bayer over birth control device Essure - Australian Broadcasting Corporation
- 15 days ago - Bayer's Stock Hits 2-Decade Low: Why It Is A Buy Again - Seeking Alpha
- 20 days ago - Bayer Showcases Growing Radiology Portfolio at RSNA 2024 - Business Wire